Ghana's implementation of the RTS,S malaria vaccine in 2019 has been evaluated in a retrospective study conducted in early 2024. Using an adapted WHO checklist, researchers assessed various aspects of the Malaria Vaccine Implementation Programme (MVIP) across 42 districts. The study aimed to provide a quantitative rating of the country's performance, addressing a gap in previous evaluations. Results showed an overall "good" performance score of 78.9%, with strengths in areas such as policy, coordination, and health worker training. However, challenges were identified in financial planning, cold chain management, and monitoring. These findings offer valuable insights for improving Ghana's immunization program and can guide other regions introducing malaria vaccines, regardless of the specific product used. The study highlights both the successes and areas for improvement in this pioneering public health initiative.
Follow the link to read more
https://malariajournal.biomedcentral.com/articles/10.1186/s12936-024-05113-8
Please Sign in (or Register) to view further.